Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced that it plans to host and operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex Pharmaceuticals
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
‘One Site Shop’ expands to respond to growing demands
PharmTech.com, 21 June 2022
Published in Pharma’s Almanac, February 2016
Manufacturing Chemist, 3 May 2023
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
Drug Delivery Technology, April 2010
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.
Google Chrome
Safari
Firefox
Edge